Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 3;9(9):e031020.
doi: 10.1136/bmjopen-2019-031020.

Patient experience of treatment decision making for wet age-related macular degeneration disease: a qualitative study in China

Wei Bian  1   2 , Junli Wan  1   2 , Mingqiong Tan  1   2 , Xiaoqing Wu  3 , Jun Su  1   2 , Lihua Wang  4
Affiliations

Patient experience of treatment decision making for wet age-related macular degeneration disease: a qualitative study in China

Wei Bian et al. BMJ Open. .

Abstract

Objectives: This study aimed to investigate the experience of patients with wet age-related macular degeneration (wAMD) in treatment decision-making process.

Design: A descriptive qualitative study was designed by using semistructured interviews, and the data analysis was conducted with the thematic analysis approach.

Participants and setting: A convenient and purposive sample of 21 participants diagnosed with wAMD was recruited from May 2018 to September 2018. The study was conducted in the Eye Clinic of Southwest Hospital of Army Medical University in Chongqing located in the southwest of China.

Results: The mean age of the participants was 64.48 years (ranging 50-81 years), and the duration of the disease ranged from 6 months to 48 months. Four major themes were identified from the original data analysis. These themes included facing the darkness (choosing from light and darkness and living in pain), constraints on decision making (doctor-oriented decision making, inadequacy of options and time), weighing alternatives (family influence, financial burden and maintaining social function) and decision-making support (professional decision-making assistance and peer support).

Conclusion: This is a qualitative study attempting to explore the patient experience of treatment decision making for wAMD disease in China. Previous literature has focused on treatment effect and symptoms, rather than the individual experience and the wide contexts from a sociocultural perspective. Further studies, such as cross-sectional studies, can be used to describe the status and determine the influencing factors of decision0making process, so as to develop an impact factor model of decision making and to formulate an intervention for patients with wAMD.

Keywords: age-related macular degeneration; qualitative study; treatment decision making.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Domains in decision-making process of patients with age-related macular degeneration
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Fisher DE, Jonasson F, Eiriksdottir G, et al. . Age-Related macular degeneration and mortality in community-dwelling elders: the age, gene/environment susceptibility Reykjavik study. Ophthalmology 2015;122:382–90. 10.1016/j.ophtha.2014.08.006 - DOI - PMC - PubMed
    1. Mitchell P, Liew G, Gopinath B, et al. . Age-Related macular degeneration. The Lancet 2018;392:1147–59. 10.1016/S0140-6736(18)31550-2 - DOI - PubMed
    1. Brown DM, Kaiser PK, Michels M, et al. . Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med Overseas Ed 2006;355:1432–44. 10.1056/NEJMoa062655 - DOI - PubMed
    1. Bian W, Wan J, Smith G, et al. . Domains of health-related quality of life in age-related macular degeneration: a qualitative study in the Chinese cultural context. BMJ Open 2018;8:e018756 10.1136/bmjopen-2017-018756 - DOI - PMC - PubMed
    1. Danner M, Vennedey V, Hiligsmann M, et al. . Comparing analytic hierarchy process and Discrete-Choice experiment to elicit patient preferences for treatment characteristics in age-related macular degeneration. Value in Health 2017;20:1166–73. 10.1016/j.jval.2017.04.022 - DOI - PubMed

Publication types

LinkOut - more resources